You are here

Enzalutamide

Pfizer and Astellas report positive data from prostate cancer therapy trial

Clinical Trials Arena

Fri, 03/17/23 - 10:02 am

prostate cancer

clinical trials

Can Pharma Influence Physician Prescribing? Unleashing New Data Using Prostate Cancer Drugs

Forbes

Sat, 08/5/17 - 09:46 am

prostate cancer

physician payments

Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer

Yahoo/MarketWired

Sat, 12/13/14 - 11:26 am

New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer

Yahoo/BusinessWire

Sun, 06/1/14 - 11:40 am

prostate cancer

metastatic prostate cancer

Medivation, Astellas prostate cancer drug meets trial goals

Yahoo/Reuters

Tue, 10/22/13 - 08:07 am

prostate cancer

Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients

Yahoo

Wed, 06/26/13 - 10:44 am

Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan

Yahoo/BusinessWire

Fri, 05/24/13 - 10:37 am

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

Yahoo/MarketWire

Sun, 09/30/12 - 10:34 am

prostate cancer

Decision Date for Medivation Drug

Yahoo/Zacks

Tue, 08/7/12 - 05:53 pm

prostate cancer

Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA

Yahoo/MarketWire

Sat, 08/4/12 - 11:22 am

prostate cancer

Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA

Yahoo/Fly on the Wall

Tue, 07/24/12 - 09:41 am

prostate cancer

Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A

Bloomberg

Mon, 07/16/12 - 08:48 am

prostate cancer

Medivation Files Enzalutamide NDA

Yahoo/Zacks

Tue, 05/22/12 - 11:16 am

prostate cancer